Featured Video
This Week in Quality Digest Live
FDA Compliance Features
Grant Ramaley
The quiet battle over medical device trade in Canada heats up
Richard Pazdur
Regulatory work must keep pace with emerging cancer therapies
Mike Richman
Understanding cultural issues that help or hurt organizational performance
Scott Gottlieb
Embracing change may mean a regulatory paradigm shift for the FDA
Vanessa Burrows
How a public exhibit led to the 1938 Food, Drug, and Cosmetic Act

More Features

FDA Compliance News
VQIP allows for expedited review and importation for approved applicants that demonstrate safe supply chains
An invite from Alcon Laboratories
Intended to harmonize domestic and international requirements
The FDA wants medical device manufactures to succeed, new technologies in supply chain managment
Pharma quality teams will have performance-oriented objectives as well as regulatory compliance goals
Strategic investment positions EtQ to accelerate innovation efforts and growth strategy
The FDA’s RMAT designation goes live
Awards help states implement multiyear produce-safety systems

More News

CBI UBM

FDA Compliance

IVT’s Validation Week 2018

An invite from Alcon Laboratories

Published: Thursday, September 6, 2018 - 17:25

(CBI UBM: Burlington, MA) -- IVT Network, the trusted source for life sciences validation and compliance knowledge, is featuring its flagship event, the 24th Annual Validation Week Oct. 22–24, 2018, in San Diego. Melanie Demakis, IVT’s senior conference producer, recently worked with Connie Hetzler, conference chairperson and global head of validation, manufacturing science, and technology at Alcon Laboratories, a division of Novartis, to discuss her participation and insight into this event.

“As a global head of validation, I know how valuable attending informative training seminars is for the success of my team,” says Hetzler. “This year, as we have for many years past, my team will be attending IVT’s 24th Annual Validation Week, where we will gain knowledge on all aspects of validation and quality, including process, facilities, computer software, and cleaning validation as well as maintaining data integrity compliance and improving quality systems.

“I highly encourage colleagues to take a look at this year’s full agenda, which includes three FDA presentations, 40 educational breakout sessions, and 32 subject matter experts on the speaking faculty. My team looks forward to exchanging perspectives with their peers, especially as there is already participation from over 100 industry professionals.”

Some of the content highlights featured at this year’s validation week include:
• Insight from the FDA Office of Regulatory Affairs: Learn from recent inspections to increase efficiencies and decrease violations
• Optimize cost reduction in process validation using a risk-based approach
• Establish a site-wide or enterprise-wide data governance program to ensure data integrity
• Bring your own challenge workshop
• Bulletproofing your CSV program: Where to start and how to build for success
• Fireside chat: Innovations in validation systems and quality culture

With more than two decades of experience in validation training, IVT Network organized a well-rounded program and makes it easy to select the sessions that best suit your training goals by identifying track topic, learning level, and industry focus.

“I hope colleagues will register to attend Validation Week to join me and my fellow speaking faculty from the FDA, AstraZeneca, Medtronic, Bausch + Lomb, Shire plc, Alexion Pharmaceuticals, Upsher-Smith and many more,” says Hetzler. “We look forward to welcoming you and learning from one another to improve our validation processes.”

For more information about the event please visit www.cbinet.com/valweek.

Discuss

About The Author

CBI UBM’s picture

CBI UBM

CBI, a division of UBM Americas, is the life sciences industry leader in providing thought leadership, actionable data, benchmarking, case studies and regulatory information through a dynamic conference platform that facilitates innovation, collaboration and elevation across the pharmaceutical, biotechnology, medical device and healthcare industries.